| Literature DB >> 24631847 |
Gemma Elliott1, Claire L Isaac2, Nils Muhlert3.
Abstract
Accelerated long-term forgetting (ALF) refers to abnormal forgetting over hours to weeks despite normal acquisition or initial consolidation. Since standardised assessments of memory typically only test at delays of up to 40-minutes, ALF may go undetected in clinical practice. The memory difficulties associated with ALF can however cause considerable distress to patients. It is important therefore that clinicians are aware that ALF may represent a distinct phenomenon that will require additional and careful assessment to aid patients' understanding of the condition and assist in developing strategies to address its effects. At the same time, ALF may also provide insight into long-term memory processes. Studies of ALF in patients with epilepsy have so far demonstrated mixed results, which may reflect differences in methodology. This review explores the methodological issues that can affect forgetting, such as the effects of age, general cognitive function, test sensitivity and initial learning. It then evaluates the extent to which existing studies have considered these key issues. We outline the points to consider when designing ALF studies that can be used to help improve their validity. These issues can also help to explain some of the mixed findings in studies of ALF and inform the design of standardised tests for assessing ALF in clinical practice.Entities:
Keywords: Accelerated long-term forgetting; Epilepsy; Forgetting rates; Methodology
Mesh:
Year: 2014 PMID: 24631847 PMCID: PMC4007031 DOI: 10.1016/j.cortex.2014.02.001
Source DB: PubMed Journal: Cortex ISSN: 0010-9452 Impact factor: 4.027
Summary of initial search.
| Search terms | Database | Matches | |
|---|---|---|---|
| “Forgetting rates” OR “rate of forgetting” OR “accelerated long-term forgetting” OR “long-term amnesia” OR “long-term forgetting” | PsychINFO | 167 | |
| MEDLINE | 122 | ||
| Web of Knowledge | 1476 | ||
| “overlearning” AND “forgetting” | PsychINFO | 2 | |
| “Accelerated long-term forgetting” AND “epilepsy” | PsychINFO | 5 | |
| MEDLINE | 28 | ||
| Web of Knowledge | 13 | ||
| “Long-term amnesia” AND “epilepsy” | PsychINFO | 3 | |
| MEDLINE | 65 | ||
| Web of Knowledge | 6 |
Fig. 1Overlearning of stimuli affects forgetting rates (replicated from Krueger et al., 1929). Half of the participants learnt a list of monosyllabic words to 100% (grey line), the other half learnt to 100% then had the same number of learning trials again (black line). Forgetting rates were decreased in the latter, overlearning, group.
Fig. 2Hypothetical forgetting curves. Loftus (1985a, 1985b) suggested that forgetting curves can be compared by examining their ‘horizontal relation’. The double-ended arrows are the same length for each example. In (A) the high-learning group (black line) shows faster forgetting than the low-learning group (grey line), as shown by the double-ended arrow outgrowing the distance between curves. In (B) the distance remains the same, indicating similar forgetting rates between the two groups, and in (C) the high-learning group shows less forgetting.
Demographic details and main findings in case studies of ALF.
| Authors (year) | ALF evidence? (delay 1st seen) | Sample size | Mean age (SD) | Sex | IQ (SD) | Brain pathology | Seizure lateralization | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | Controls | Patient | Controls | Patient | Controls | Patient | Controls | Patient | Patient | ||
| Yes (40 days) | 1 (P.A.) | 4 | 62 | 65.3 | F | F | 124 | 121.1 | Left-HC | L | |
| Yes (1 week) | 1 | 24 | 50 | 67.7 | M | 10M 14F | 136 | 120 | Left-HC | L | |
| Yes (7 days) | 1 (J.E.) | 1 | 18 | 18 | M | M | 90 | – | L-AMG | L | |
| Yes (3 weeks) | 1 (J.L.) | 10 | 40 | 41.1 (3.03) | F | F | 122 | 113.5 (8.2) | Bi-TL HC normal | R | |
| Yes (1 day) | 1 (R.Y.) | 8 | 63 | 66.3 (4.9) | M | 3M – 5F | 118 | 117.9 (6.29) | None | R | |
| Experiment 2 | Yes (1 day) | 1 (R.Y.) | 6 | 63 | 61.8 (5.41) | M | M | 118 | 122 (5.79) | R | |
| Yes (6 weeks) | 1 (S.P.) | 3 | 50 | 46.3 | F | F | 94 | – | Left-TL | – | |
| Yes (40 days) | 1 (P.A.) | 4 | 62 | 65.3 | F | F | 124 | 121.1 | Left-HC | L | |
| Yes (4 days) | 2 (S.K., E.B.) | 10 young, 4 old | 36, 73 | – | M, M | M | 92, 124 | 101.2 young, 127 old | Right-TL, normal | L, – | |
| Yes (7 days) | 1 (G.B.) | 2 | 65 | 63.5 | M | – | 120 | – | Mild ventricular asymmetry L > R | L | |
| Yes (3 weeks) | 1 (J.L.) | 10 | 41 | 40.6 (2.7) | F | – | 122 | 116 (10.9) | Bi-TL HC normal | R | |
| Yes (55 min) | 1 (R.Y.) | 5 | 68 | 66.3 (4.9) | M | 2M – 3F | 116 | 117.9 (6.29) | None | R | |
| Yes (24 h) | 1 (J.T.) | 1 | 42 | 40 | M | M | 127 | – | Bi-MTL | Bi | |
M = male, F = female, – = information not presented, R = right, L = left, Bi = bilateral, TL = temporal lobe, MTL = mesial temporal lobe, HC = hippocampus, AMG = amygdala.
Demographic details and main findings in group studies of ALF.
| Authors (year) | ALF evidence? (delay) | Sample size | Mean age (SD) | Sex | IQ (SD) | Brain pathology | Seizure lateralization | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | Controls | Patients | Controls | Patients | Controls | Patients | Controls | Patients | Patients | ||
| No (24 h) | 42 | 49 | 37 (11.4) | 37 (11.8) | 14M | 22M | 93.5 (14.2) | 104 (12.7) | None | 20R | |
| No (2 weeks) | 25 | 25 | 39 (10) | 35 (11) | 10M | 8M | 94 (12) | 104 (10) | None 6 postop | 6R, 11L, 2 Bi | |
| Yes (8 weeks) | 21 (14 TLE) | 16 | 33.76 (9.72) | 46.25 (14.54) | 7M | 6M | 103.65 (12.72) | 101.88 (13.20) | HS 5/14 TLE group | 10R | |
| Yes (1 week) | 24 | 24 | 67 (8.7) | 67.7 (8.2) | 14M | 10M | 124.3 (10.4) | 120 (14.4) | None | – | |
| Yes (1 week) | 22 | 20 | 66.4 (8.8) | 67.5 (8.6) | 12M | 8M | 124.7 (10.7) | 121.2 (14.9) | <HC volume | – | |
| Yes (1 week) | 22 | 20 | 66.4 (8.8) | 67.5 (8.6) | 12M | 8M | 124.7 (10.7) | 121.2 (14.9) | <HC, perirhinal volume | ||
| Yes (1 week) | 21 | 21 | 11.5 | 11.9 | 7M | – | 99.4 (14.4) | 98.5 (11.6) | – | IGE | |
| Yes (1 week) | 7 | 25 | 39.71 (15.8) | 38.1 (14.6) | 3M | 12M | 94.0 (8.2) | 99.4 (4.7) | 5 MTS, 1 left AMG abnormality, 1 right HC volume loss | 4R | |
| Yes (24 h) | 39 | 15 | 32.6–41.8 | 40.4 (10.9) | – | – | 104–108 | 108.9 (10.1) | 3 cortical lesions, HC lesions, 1 glioma | 4L, 3R, 15 nonlateralised/generalised | |
| Yes (7 days) | 20 | 41 | 10.8 (2.5) | 11.2 (2.6) | 10M | 20M | 102.0 (10.6) | 111.3 (11.2) | None | IGE | |
| No (13 days) | 24 | 25 | 38 (11.82) | 37.5 (10.88) | 14M | 13M | – | – | None | 12R | |
| Yes (1 week) | 55 | 21 | 26.9 | 29.4 | 27M | 11M | 100 (11) | 110 (12) | 10 none, 14 HS, 16 tumours, 4 heterotopia, 11 other TL | 27R | |
| Yes (1 week) | 17 | 18 | 65.5 (8.8) | 68.3 (8.8) | 9M | 7M | 123.2 (11.4) | 119.2 (16.0) | None | – | |
| Yes (1 day) | 21 | 21 | 31 (7.5) | 40 (11.4) | 10M | 6M | 91.4 (9.9) | 101 (10.1) | 6 postop | 8R | |
| Yes (4 weeks) | 70 | 59 | 33 (9.5) | 31 (9.5) | 29M | 19M | – | – | 11 TL lesion | – | |
| Yes (6 weeks) | 7 | 7 | 57 (8.1) | 64 | 6M | – | 115.3 (8.5) | 110.5 (6.7) | None | – | |
| Yes (1 day) | 11 | 11 | 68.6 (9.9) | 66.0 (8.3) | 11M | 1M | 122.7 (6.0) | 119.6 (13.0) | None | – | |
| Yes (3 weeks) | 28 (14 TLE, 14 IGE) | 15 | 46.4 (11.0) TLE 31.6 (14.6) IGE | 33.3 (15.4) | 4M/10F TLE | 7M | 112.0 (13.5) TLE 113.1 (15.5) IGE | 117.5 (12.2) | 7 MTS, 1 right glioma, 1 right stroke, 1 right epidermoid cyst | 7R | |
| Mixed (4 weeks) | 14 | 17 | 33.6 (10.1) | 37.4 (12.8) | 6M | 3M | 98.3 (6.7) | 101.6 (5.2) | 5 left HS or atrophy, 3 right HS or atrophy | 9L | |
| Yes (6 weeks) | 5 | 15 | 42.6 (9.3) | 42.3 (9.6) | 4M | – | 115 (10.4) | – | 1 right MTS, 1 left hippocampal dysplasia | 1L | |
| Yes (6 weeks) | 27 | 22 | 36.7 | 41.14 (12.24) | – | – | 104.96 | 111.14 (10.10) | 15 left HS | – | |
Studies reporting separate statistics for right and left TLE patients have been combined in this summary. M = male, F = female, – = information not presented, R = right, L = left, Bi = bilateral, HS = hippocampal sclerosis, postop = undergone epilepsy surgery, IGE = idiopathic generalised epilepsies. MTS = Mesial temporal sclerosis.
Case reports of ALF in epilepsy: methodology evaluation.
| Authors (year) | Matched controls? | Test material | Recall & recognition? | Ceiling & floor effects avoided? | Rehearsal avoided? | Immediate delay after 15 sec? | Matching procedure? | Initial learning equated? |
|---|---|---|---|---|---|---|---|---|
| Age – yes | Verbal | Yes | No | No | No | No | Yes | |
| Age – yes | Verbal | No | No | No | No | Yes | Yes | |
| Age – yes | Verbal | No | Yes | No | No | No | Yes | |
| Age – yes | Verbal | No | No | Yes | Yes | Yes | Yes | |
| Age – yes | Verbal | Yes | No | Yes | No | No | Yes | |
| Age – yes | Verbal | Yes | No | No | No | No | Yes | |
| Age – yes | Verbal | Yes | No | No | No | No | Yes | |
| Age – yes | Verbal | Yes | Yes | No | No | Yes | Yes | |
| Age – yes | Verbal | No | No | No | No | No | Yes | |
| Age – yes | Verbal | Yes | No | Yes | Yes | Yes | Yes | |
| Age – yes | Verbal | No | No | No | No | Yes | Yes |
Group studies of ALF in epilepsy: methodology evaluation.
| Authors (year) | Matched controls? | Test material | Recall & recognition? | Ceiling & floor effects avoided? | Rehearsal avoided? | Immediate delay after 15 sec? | Matching procedure included? | Initial learning equated? |
|---|---|---|---|---|---|---|---|---|
| Age – yes | Verbal | No | Yes | Yes | No | Yes | No | |
| Age – yes | Verbal | Yes | Yes | Yes | No | No | No | |
| Age – yes | Verbal | Yes | No | Yes | No | Yes | Yes | |
| Age – yes | Verbal | Yes | No | Yes | No | Yes | Yes | |
| Age – yes | Verbal | No | Yes | No | No | Yes | Yes | |
| Age – yes | Verbal | No | Yes | No | No | Yes | Yes | |
| Age – yes | Verbal | Yes | Yes | Yes | No | Yes | No | |
| Age – yes | Verbal Visuo-spatial | Yes | Yes | Yes | Yes | Yes | 6/8 tests | |
| Age–yes IQ – yes | Verbal | No | No | No | No | Yes | Yes | |
| Age – yes | Verbal | Yes | No | No | Yes | Yes | Yes | |
| Age – yes | Visual | No | Yes | No | No | Yes | No | |
| Age – yes | Verbal | No | Yes | Yes | No | No | No | |
| Age – yes | Verbal | Yes | Yes | Yes | No | Yes | Yes | |
| Age – no | Verbal | No | Yes | Yes | No | Yes | Yes | |
| Age – yes | Verbal | No | Yes | No | No | No | No | |
| Age – yes | Verbal | Yes | No | No | No | No | Yes | |
| Age – yes | Verbal | No | Yes | No | Yes | Yes | Yes | |
| Age – yes | Verbal | Yes | Yes | Yes | Yes | Yes | Yes | |
| Age – yes | Verbal | Yes | No | No | No | Yes | Yes | |
| Age – yes | Verbal | Yes | No | No | No | No | Yes | |
| Age – yes | Verbal | No | Yes | No | Yes | Yes | Yes |
A subset of control participants were examined with matched age and IQ to the TLE patients.